The ultrasound contrast agent for use in HyCoSy procedures is instrumental in detecting potential reasons for infertility associated with fallopian tube blockages or uterine abnormalities. Credit: ...
MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical ...
Bracco Imaging, a global leader in diagnostic imaging, announced that its ultrasound contrast agent SonoVue has been approved by the China's National Medical Products Administration (NMPA) for use in ...
China's National Medical Products Administration (NMPA) has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles, for use in a contrast-enhanced ultrasound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results